2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels

Daniel A. Pollyea; Holbrook E. Kohrt; Bing Zhang; James Zehnder; David Schenkein; Valeria Fantin; Kimberly Straley; Aparna Vasanthakumar; Omar Abdel-Wahab; Ross Levine; Lucy A. Godley; Bruno C. Medeiros

doi:10.3109/10428194.2012.701009

2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels

Daniel A. Pollyea^*, Holbrook E. Kohrt, Bing Zhang, James Zehnder, David Schenkein, Valeria Fantin, Kimberly Straley, Aparna Vasanthakumar, Omar Abdel-Wahab, Ross Levine, Lucy A. Godley, Bruno C. Medeiros

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	408-410
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	54
Issue number	2
DOIs	https://doi.org/10.3109/10428194.2012.701009
State	Published - Feb 2013

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428194.2012.701009

Cite this

Pollyea, D. A., Kohrt, H. E., Zhang, B., Zehnder, J., Schenkein, D., Fantin, V., Straley, K., Vasanthakumar, A., Abdel-Wahab, O., Levine, R., Godley, L. A., & Medeiros, B. C. (2013). 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels. Leukemia and Lymphoma, 54(2), 408-410. https://doi.org/10.3109/10428194.2012.701009

@article{c094d9d121514ebc874f55f8ca23b64e,

title = "2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels",

author = "Pollyea, {Daniel A.} and Kohrt, {Holbrook E.} and Bing Zhang and James Zehnder and David Schenkein and Valeria Fantin and Kimberly Straley and Aparna Vasanthakumar and Omar Abdel-Wahab and Ross Levine and Godley, {Lucy A.} and Medeiros, {Bruno C.}",

year = "2013",

month = feb,

doi = "10.3109/10428194.2012.701009",

language = "English (US)",

volume = "54",

pages = "408--410",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "2",

}

Pollyea, DA, Kohrt, HE, Zhang, B, Zehnder, J, Schenkein, D, Fantin, V, Straley, K, Vasanthakumar, A, Abdel-Wahab, O, Levine, R, Godley, LA & Medeiros, BC 2013, '2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels', Leukemia and Lymphoma, vol. 54, no. 2, pp. 408-410. https://doi.org/10.3109/10428194.2012.701009

2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels. / Pollyea, Daniel A.; Kohrt, Holbrook E.; Zhang, Bing et al.
In: Leukemia and Lymphoma, Vol. 54, No. 2, 02.2013, p. 408-410.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia

T2 - Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels

AU - Pollyea, Daniel A.

AU - Kohrt, Holbrook E.

AU - Zhang, Bing

AU - Zehnder, James

AU - Schenkein, David

AU - Fantin, Valeria

AU - Straley, Kimberly

AU - Vasanthakumar, Aparna

AU - Abdel-Wahab, Omar

AU - Levine, Ross

AU - Godley, Lucy A.

AU - Medeiros, Bruno C.

PY - 2013/2

Y1 - 2013/2

UR - http://www.scopus.com/inward/record.url?scp=84872014953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872014953&partnerID=8YFLogxK

U2 - 10.3109/10428194.2012.701009

DO - 10.3109/10428194.2012.701009

M3 - Letter

C2 - 22680765

AN - SCOPUS:84872014953

SN - 1042-8194

VL - 54

SP - 408

EP - 410

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 2

ER -

2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: Predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this